597 analyst ratings (weighted) · Buy
Consumer Discretionary Leads at 25.2% Upside as Staples Trail
Consumer Discretionary leads and Consumer Staples lags on analyst implied upside across our 11-sector S&P 500 watchlist as of September 21, 2026.
Read article →This page provides a comprehensive analysis of large-cap stocks within the Healthcare sector. Compare target prices, upside potential, and key financial metrics to identify promising investment opportunities.
| Ticker | Price | Avg Target | Upside | Market Cap | P/E Ratio (TTM) | Beta (Volatility) | Opinion |
|---|---|---|---|---|---|---|---|
BSX Boston Scientific Corporation 29 · Buy | $43.92 | $61.00 | +38.89% | $63.65B | 17.78 | 0.57 | buy |
SYK Stryker Corporation 25 · Buy | $272.36 | $369.00 | +35.48% | $104.47B | 28.25 | 0.77 | buy |
ZTS Zoetis Inc. 14 · Buy | $71.05 | $96.00 | +35.12% | $29.36B | 11.59 | 0.73 | buy |
CVS CVS Health Corporation 25 · Strong Buy | $89.13 | $116.28 | +30.46% | $113.99B | 23.52 | 0.58 | strong buy |
UNH UnitedHealth Group Incorporated 25 · Buy | $376.59 | $481.72 | +27.92% | $338.03B | 24.22 | 0.62 | buy |
CI The Cigna Group 24 · Buy | $272.01 | $341.83 | +25.67% | $71.88B | 11.25 | 0.32 | buy |
ABT Abbott Laboratories 25 · Buy | $101.29 | $120.26 | +18.73% | $175.27B | 32.78 | 0.59 | buy |
MDT Medtronic plc. 24 · Buy | $88.64 | $104.83 | +18.27% | $113.38B | 21.83 | 0.57 | buy |
ISRG Intuitive Surgical, Inc. 29 · N/A | $405.18 | $476.34 | +17.56% | $145.17B | 46.52 | 1.47 | none |
ELV Elevance Health, Inc. 21 · Buy | $396.09 | $451.38 | +13.96% | $85.90B | 17.51 | 0.70 | buy |
MCK McKesson Corporation 14 · Buy | $866.64 | $979.36 | +13.01% | $101.04B | 23.25 | 0.31 | buy |
LLY Eli Lilly and Company 29 · Buy | $1183.46 | $1325.39 | +11.99% | $1.06T | 39.69 | 0.50 | buy |
VRTX Vertex Pharmaceuticals Incorpor 28 · Buy | $526.19 | $570.32 | +8.39% | $133.37B | 30.24 | 0.32 | buy |
REGN Regeneron Pharmaceuticals, Inc. 26 · Buy | $788.04 | $850.88 | +7.97% | $81.13B | 19.49 | 0.19 | buy |
BDX Becton, Dickinson and Company 12 · Buy | $183.82 | $195.67 | +6.44% | $50.07B | 31.86 | 0.28 | buy |
ABBV AbbVie Inc. 28 · Buy | $264.34 | $278.61 | +5.40% | $467.12B | 74.46 | 0.28 | buy |
GILD Gilead Sciences, Inc. 26 · Buy | $150.93 | $158.65 | +5.12% | $187.15B | 15.26 | 0.35 | buy |
HCA HCA Healthcare, Inc. 22 · Buy | $435.61 | $454.23 | +4.27% | $94.31B | 14.60 | 1.11 | buy |
MRK Merck & Company, Inc. 26 · Buy | $148.78 | $153.65 | +3.28% | $367.07B | 119.02 | 0.23 | buy |
DHR Danaher Corporation 23 · Strong Buy | $224.49 | $230.83 | +2.82% | $157.81B | 40.02 | 0.81 | strong buy |
IQV IQVIA Holdings, Inc. 18 · Strong Buy | $270.37 | $277.94 | +2.80% | $44.50B | 33.67 | 1.19 | strong buy |
JNJ Johnson & Johnson 22 · Buy | $271.22 | $277.91 | +2.47% | $653.61B | 31.46 | 0.23 | buy |
PFE Pfizer, Inc. 26 · Buy | $28.67 | $28.88 | +0.72% | $163.41B | 37.72 | 0.30 | buy |
TMO Thermo Fisher Scientific Inc 27 · Buy | $675.00 | $653.11 | -3.24% | $249.58B | 36.37 | 0.85 | buy |
AMGN Amgen Inc. 29 · Hold | $414.61 | $389.22 | -6.12% | $224.15B | 25.77 | 0.43 | hold |
When investing in the Healthcare sector, consider the average upside potential and the consensus of Wall Street analysts. Pay attention to the P/E ratio and Beta to understand the valuation and volatility of each stock relative to the broader market.
A. Based on Wall Street analyst consensus, the Healthcare sector currently has an average upside of +13.1% across 25 large-cap stocks.
A. Boston Scientific Corporation (BSX) leads with +38.9% upside. Consensus target price is $61.00 vs. current price of $43.92.
A. All sector data is refreshed once daily via an automated workflow. Analyst target prices and recommendations are sourced from Yahoo Finance.